Dean Kingston and Barry Vant-Hull, Ph.D., will be central to IntraMed Diagnostics’ development of onsite in vitro diagnostic drugs of abuse screening and health diagnostics applications.
(PRWeb May 15, 2013)
Read the full story at http://www.prweb.com/releases/2013/5/prweb10732936.htm
